Advocates fear New York state could be taking a step back when it comes to biomarker testing access for those with Medicaid.

Cardiovascular diseases remain the leading cause of death worldwide, accounting for nearly 20 million deaths each year. Rapid ...

Biomarker testing has the potential to streamline diagnosis, treatment planning, and anticipation of treatment risks, if done right.

Imagine this: someone you love has just heard the words “you have cancer.” They are meeting with their oncologist – perhaps even me, or one of my colleagues – and come to understand that there is ...

A group of cancer survivors from the Bronx and statewide gathered outside Gov. Kathy Hochul’s NYC office on Third Avenue on ...

A bill that would expand coverage of biomarker testing in Tennessee passed the Senate Commerce and Labor Committee.

A group of cancer survivors from around the state is set to gather outside Gov. Kathy Hochul’s Manhattan office on Tuesday.

Every year, America’s medical research pipeline produces new treatments, new technologies and new ways to improve patient care. Often, the real challenge is ensuring policy keeps pace with these ...

Across all cancer types, less than 50% of patients underwent biomarker testing before first-line treatment. Many patients with advanced cancer do not receive guideline-recommended biomarker testing ...

Young lung cancer patients have a higher incidence of targetable biomarkers, necessitating comprehensive testing for ALK fusions and EGFR mutations. Repeat biomarker testing is essential when ...

Please provide your email address to receive an email when new articles are posted on . Biomarker testing appeared inconsistent, with rates not reflecting guidelines. Less than 25% of oncologists ...

At the Tennessee Capitol, patients, advocates and families came prepared on Tuesday afternoon to tell lawmakers something ...